The Henry Ford Hospital Department of Dermatology Residency Program has trained 287 dermatologists in its 59 years of existence. With offices both in urban Detroit and the surrounding metro area,…
Read More
INTRODUCTION This chart summarizes clinical presentations, common locations, and histopathological findings of adnexal tumors from follicular, sebaceous, and eccrine origins. The last column summarizes associations with genetic syndromes and other…
Read More
INTRODUCTION An African-American male, aged 60 years, presented with a 2-month history of asymptomatic nodules on his buttocks and thighs. On examination, there were 5 firm, nontender, subcutanteous nodules measuring…
Read More
Evidence for Supplement Use in Atopic DermatitisINTRODUCTION As the prevalence of atopic dermatitis increases, so does interest in “natural” treatment options as well as prescription medications to address this chronic…
Read More
Watson's Generic Lidoderm® Receives FDA Approval Watson Laboratories, Inc., a subsidiary of Watson Pharmaceuticals, Inc. has announced that it has received final approval from the FDA on its Abbreviated New…
Read More
PSORIASIS Phase II Randomized Double Blinded Placebo Controlled, Multiple-dose Regimen Study to Assess the Rate of Histological Clearance and Effect on Molecular Pathways as Well as on Biomarkers of 12…
Read More
INTRODUCTION Hyperpigmentary disorders of the skin such as melasma, age spots, and solar lentigines result from excessive epidermal melanin synthesized by cutaneous melanocytes.1 Thus, the unique biochemical pathway of melanogenesis…
Read More
INTRODUCTION Enfuvirtide, the prototype for a novel class of antiretroviral (ARV) agents deemed to be fusion protein inhibitors, is a prescription drug used for the treatment of human immunodeficiency virus…
Read More
INTRODUCTIONOf all the procedures that the average dermatologist performs today, none is more common than the skin biopsy. Although the premise behind local anesthesia is to reduce the pain and…
Read More
INTRODUCTIONProton pump inhibitors (PPIs) are the most potent gastric acid–suppressing agents used for preventing nonsteroidal anti-inflammatory drug (NSAID)–induced ulceration and for treating peptic ulcers and other acid-related conditions.1,2 The first…
Read More
INTRODUCTION The study of percutaneous absorption (PA) of substances is relevant to the fields of dermatopharmacology (such as in the cases of drug delivery methods and chemical warfare) and occupational…
Read More